Managing Metastatic Prostate Cancer In Your Urological Oncology Practice edited by K.C Balaji.

This text provides a comprehensive review of pathophysiology, molecular and cell biology aspects of CRPC, discusses all major clinical trials that have led to approval of 6 new drugs since 2004, explores the role of bone preservation strategies, in depth analysis of combination and sequencing strate...

Full description

Saved in:
Bibliographic Details
Corporate Author: SpringerLink (Online service)
Other Authors: Balaji, K.C (Editor)
Format: eBook
Language:English
Published: Cham : Springer International Publishing : Imprint: Springer, 2016.
Edition:1st ed. 2016.
Series:Springer eBook Collection.
Subjects:
Online Access:Click to view e-book
Holy Cross Note:Loaded electronically.
Electronic access restricted to members of the Holy Cross Community.
Table of Contents:
  • Introduction
  • Pathophysiology of Castration-Resistant Prostate Cancer
  • Androgen Receptor Signaling in Castration Resistant Prostate Cancer
  • Non-Androgen Signaling Pathways in Castration-Resistant Prostate Cancer
  • Predictive Models in Castration Resistant Prostate Cancer
  • Docetaxel in Advanced and Castration Resistant Prostate Cancer
  • Combination Treatment Strategies with Docetaxel in Patients with Metastatic Prostate
  • Cancer Vaccines in Castration Resistant Prostate Cancer – An evolution in design
  • Abiraterone for the treatment of mCRPC
  • Enzalutamide in Metastatic Castration Resistant Prostate Cancer
  • Radium-223 in Metastatic Castrate Resistant Prostate Cancer
  • Cabazitaxel for the Treatment of Prostate Cancer
  • Sequencing Therapies in Metastatic Castration Resistant Prostate Cancer
  • Bone Preservation Strategies for Men on Androgen Deprivation Therapy
  • Novel Therapies in Castration-Resistant Prostate Cancer.